U.S. Tech Hardware Stock News

NasdaqGS:SRAD
NasdaqGS:SRADHospitality

Sportradar Group (SRAD) Could Be 31% Undervalued Following Fraud Lawsuits

Sportradar Group (NasdaqGS:SRAD) is under pressure after multiple securities fraud class action lawsuits accused the company of working with black market gambling operators despite public assurances about strict compliance and due diligence standards. See our latest analysis for Sportradar Group. At a latest share price of $14.70, Sportradar Group has seen its 30 day share price return rise 12.82%, but this recent momentum contrasts with a year to date share price return that is down 36.96%...
NYSE:NTB
NYSE:NTBBanks

Bank Of N.T. Butterfield & Son (NTB) Hits All Time High On A Fair Value Debate

Bank of N.T. Butterfield & Son (NTB) recently touched an all time high of US$59.37, drawing fresh attention to how the bank’s cross border operations, balance sheet mix, and recent results align with current investor expectations. See our latest analysis for Bank of N.T. Butterfield & Son. Against this backdrop, Bank of N.T. Butterfield & Son’s recent all time high sits alongside a 30 day share price return of 5.21% and a 90 day share price return of 13.68%. Its 1 year total shareholder...
NYSE:AMN
NYSE:AMNHealthcare

The Bull Case For AMN Healthcare Services (AMN) Could Change Following New Commercial And People Leadership Appointments

Earlier this month, AMN Healthcare appointed Kristy Willis as Chief Commercial Officer and Holly Novak as Chief People Officer, consolidating commercial functions and elevating its human resources leadership to support its AI-enabled WorkWise talent platform and broader workforce solutions portfolio. The dual appointments highlight AMN Healthcare’s emphasis on integrating sales, marketing, and people operations to support its next phase of growth, innovation, and organizational...
NYSE:CARR
NYSE:CARRBuilding

Does Carrier Global's (CARR) Climate Solutions Leadership Shift Clarify Its European Execution Strategy?

Earlier this month, Carrier Global Corporation announced that Thomas Donato was appointed President of Climate Solutions Europe, succeeding Thomas Heim, with both leaders collaborating to ensure a smooth transition for employees, customers and partners. The move pairs Donato’s broad industrial technology leadership background with the foundation Heim built integrating Viessmann Climate Solutions, potentially shaping how Carrier executes its European climate and energy strategy. Next, we’ll...
NasdaqGS:VNOM
NasdaqGS:VNOMOil and Gas

Viper Energy (VNOM) Extends Credit Terms, Is The Stock Still Undervalued?

Why Viper Energy’s new credit terms and options activity matter now Viper Energy (VNOM) has just amended its credit agreement, extending the facility to 2031, lifting total commitments to $2.0b and trimming borrowing costs, while options markets indicate expectations for a sharp share move. For you as an investor, this combination of expanded credit capacity, a longer maturity profile and lower interest and fee terms, together with elevated implied volatility, puts Viper Energy squarely in...
NYSE:CAAP
NYSE:CAAPInfrastructure

Is Corporación América Airports (CAAP) Below Fair Value Following Its May Traffic Update?

May traffic update in focus Corporación América Airports (NYSE:CAAP) recently released its May 2026 operating statistics, showing monthly passenger, cargo, and aircraft movement figures that were close to last year, with year to date volumes slightly higher across these categories. This type of traffic update gives you a timely read on how busy the company’s airports are and how current activity compares with the same period in the prior year. See our latest analysis for Corporación América...
NYSE:CNA
NYSE:CNAInsurance

Is CNA Financial (CNA) Undervalued After Its Earnings Miss?

CNA Financial (CNA) recently reported quarterly results with revenue and earnings per share below analyst expectations, and the stock has fallen 4.9% since the release as investors reassess sector and company specific risks. See our latest analysis for CNA Financial. Despite the post earnings setback, CNA Financial’s recent share price action has been relatively steady, with a 30 day share price return of 6.52% and a 1 year total shareholder return of 10.46% that compares with a three year...
NYSE:ALLE
NYSE:ALLEBuilding

How Investors May Respond To Allegion (ALLE) After Longbow’s Upgrade On Non-Residential, Digital Access Outlook

In June 2026, research firm Longbow upgraded Allegion plc to a more positive rating, highlighting the company’s prospects in non-residential construction and electronic access solutions. This shift in analyst stance has drawn attention to Allegion’s exposure to evolving security needs in commercial buildings and digital access systems. We’ll now examine how Longbow’s more optimistic view on Allegion’s non-residential and electronic access growth shapes the broader investment narrative. We've...
NYSEAM:HYLN
NYSEAM:HYLNElectrical

Why Hyliion Holdings (HYLN) Is Down 17.9% After Short Seller Questions Key Sales Pipeline Deal

Recently, Hyliion Holdings came under pressure after short seller Pelican Way Research questioned whether a US$133 million letter of intent with VFG Holdings, representing roughly one-third of Hyliion’s reported sales pipeline, is backed by a customer with sufficient operational and financial substance. The report also criticized Hyliion’s capital allocation and relatively high executive pay against weak revenue performance, raising concerns about how much of its projected growth is...
NasdaqCM:NEO
NasdaqCM:NEOHealthcare

Does NeoGenomics' (NEO) 2032 Convertible Note Deal Reveal a New Oncology Diagnostics Playbook?

NeoGenomics, Inc. recently completed a US$275,000,000 Rule 144A offering of 0.75% convertible senior unsecured notes due July 1, 2032, following oncology research presentations at the 2026 ASCO meeting. This combination of capital raising and scientific visibility could influence how investors think about the company’s balance sheet flexibility and long-term oncology diagnostics positioning. We’ll now examine how the new 2032 convertible notes might reshape NeoGenomics’ investment narrative...
NYSE:MPC
NYSE:MPCOil and Gas

Marathon Petroleum Stock Leads 3 Oil Exposure Picks As Inflation Fears Return

Rising Middle East tensions and fresh inflation worries are pulling oil back into the spotlight, and that ripple effect is running straight through parts of the stock market. With CPI running at 4.2% in May and oil costs feeding into everything from transport to consumer goods, some companies could see a lift from higher energy prices while others face tougher margin pressure. This article looks at three stocks exposed to the latest geopolitical and inflation headlines, highlighting one that...
NYSE:CHWY
NYSE:CHWYSpecialty Retail

Consumer Discretionary Stocks That Could Benefit Most From Lower Rates And Stronger US Growth

With talk of a potential 3% U.S. GDP growth rate, a “3-3-3” policy framework, and pressure on the Federal Reserve to cut interest rates, the backdrop for consumer discretionary stocks looks very different from just a few quarters ago. Slower recent growth and still elevated financing costs mean not every stock will respond in the same way. This article focuses on U.S. Consumer Discretionary Stocks that appear closely tied to these macro shifts, and will walk through 3 stocks from the screener...
NYSE:CBRE
NYSE:CBREReal Estate

How CBRE’s Role in America’s Workforce Academy Will Impact CBRE Group (CBRE) Investors

Recently, Meta, the National Urban League, the Associated Builders and Contractors, and CBRE announced America’s Workforce Academy, a US$115 million program to provide free skilled trades training with guaranteed job placement on AI infrastructure projects, marking the largest private-sector commitment of its kind in US history. This initiative underscores how a shortage of electricians, plumbers, welders, and other tradespeople is emerging as a key constraint on AI infrastructure build-out,...
NasdaqGS:PRDO
NasdaqGS:PRDOConsumer Services

The Bull Case For Perdoceo Education (PRDO) Could Change Following Fresh Undervaluation Signals In Key Ratios

Recent analysis highlighted that Perdoceo Education holds a Zacks Rank #2 with a high Value grade, alongside a price-to-book ratio of 2.3 versus an industry average of 3.24 and a price-to-cash flow ratio of 12.58, suggesting stronger value credentials than many peers. This combination of valuation metrics points to a perception that Perdoceo may be undervalued and supported by a solid cash generation profile, helping explain why investors have recently paid closer attention to the stock. We...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

Rhythm Pharmaceuticals (RYTM) Is Up 7.9% After Promising Early PWS Data for Setmelanotide - What's Changed

In June 2026, Rhythm Pharmaceuticals reported preliminary six-month Phase 2 data for setmelanotide in Prader-Willi syndrome, showing improvements in BMI, body composition, hyperphagia, and anxiety-related behaviors, with safety consistent with prior experience and 17 of 18 patients remaining on therapy. The breadth of clinically relevant benefits across weight, hunger, and behavioral measures in a difficult-to-treat PWS population could meaningfully influence how investors think about...
NYSE:HOG
NYSE:HOGAuto

Third Avenue’s Turnaround Bet Might Change The Case For Investing In Harley-Davidson (HOG)

Earlier this year, Third Avenue Value Fund disclosed a new position in Harley-Davidson, citing recent management changes and efforts to clear aging dealership inventory and reposition the product mix after several years of sales declines. The fund’s interest, alongside management’s focus on operational improvements despite weaker motorcycle demand and constrained free cash flow, is drawing fresh attention to Harley-Davidson’s turnaround prospects and execution risks. We’ll now examine how...
NYSE:EFX
NYSE:EFXProfessional Services

Equifax (EFX) On Cloud Migration Progress And A Valuation Question

Equifax stock performance snapshot Equifax (EFX) has drawn investor attention after a period of weaker share performance, with the stock down 7% over the past month and 11.6% over the past 3 months based on provided returns. Over longer horizons, Equifax is also showing declines, with total returns down 28.7% year to date and 41.1% over the past year. The 3 and 5 year total return figures are also negative. See our latest analysis for Equifax. At the latest share price of $152.53, Equifax has...
NYSE:LPG
NYSE:LPGOil and Gas

Did Dorian LPG’s Fleet Refresh and US$256 Million VLGC Sale Just Shift Its (LPG) Investment Narrative?

Dorian LPG Ltd. recently announced it agreed with HD Hyundai to build a new 90,000 cbm VLGC for delivery in July 2029 at a price of about US$115 million, and entered memorandums of agreement to sell three VLGCs built in 2014–2015 for roughly US$256 million in proceeds, expected to close by the fourth quarter of 2026. Together, these transactions highlight an active reshaping of Dorian LPG’s fleet mix, with older vessels being recycled into cash while a single, larger newbuild order refreshes...
NasdaqGS:MGEE
NasdaqGS:MGEEElectric Utilities

Do Analyst Views on Renewables Reveal a Deeper Shift in MGE Energy’s Earnings Profile (MGEE)?

Earlier in June, Ladenburg upgraded MGE Energy, Inc. to Buy and Freedom Broker initiated coverage with a Hold rating, both emphasizing the company’s valuation and regulated utility profile. Analysts highlighted how MGE Energy’s capital investments and rollout of renewable energy projects are supporting the company’s defensive earnings mix. Next, we’ll examine how this supportive analyst commentary on MGE Energy’s renewable investments shapes the company’s broader investment narrative. We've...
NasdaqGS:AFRM
NasdaqGS:AFRMDiversified Financial

Will a Golden Cross and Higher Earnings Estimates Change Affirm Holdings' (AFRM) Fintech Narrative?

Affirm Holdings recently saw its 50-day simple moving average cross above its 200-day simple moving average, forming a golden cross that is often viewed as a bullish technical signal, alongside analysts revising earnings estimates higher. This combination of a widely watched technical pattern and improving earnings expectations has drawn renewed attention to how investors are reassessing Affirm’s outlook within the broader financial technology space. We’ll now examine how the golden cross...
NasdaqGS:IDXX
NasdaqGS:IDXXMedical Equipment

Are IDEXX Laboratories’ (IDXX) New SDMA and Tapeworm Tests Deepening Its Diagnostics Moat?

In May 2026, IDEXX Laboratories expanded its Fecal Dx antigen testing to detect taeniid tapeworm species and integrated the SDMA renal biomarker into Catalyst CLIPs, with the upgraded services rolling out to US and Canadian reference lab customers at no additional cost from late June. These enhancements broaden IDEXX’s diagnostic menu in parasitology and kidney assessment, potentially increasing the clinical relevance and stickiness of its veterinary testing platforms. We’ll now examine...
NYSE:FIS
NYSE:FISDiversified Financial

Fidelity National Information Services (FIS) Could Be 35% Undervalued Following New Banking Platform Wins

Fidelity National Information Services (FIS) has drawn fresh investor attention after launching a secondary loan trading platform within its commercial lending suite and securing a core banking deal with First Commerce Bank, alongside ongoing leadership changes. See our latest analysis for Fidelity National Information Services. Despite launching new lending platforms, securing the HORIZON core win with First Commerce Bank and progressing with leadership changes, Fidelity National Information...
NYSE:MD
NYSE:MDHealthcare

Is Ongoing Sales Weakness and Softer Returns Reshaping the Investment Case For Pediatrix (MD)?

Pediatrix Medical Group recently reported that sales have fallen each year for the past two years, with the latest outlook pointing to flat revenue and weakening returns on capital from its recent investments. This combination of declining top-line momentum and eroding capital efficiency has raised fresh questions about how effectively the company is allocating resources in its specialized pediatric and neonatal care portfolio. We’ll now examine how the ongoing sales decline and...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

ImmunityBio (IBRX) Valuation In Focus After Russell 1000 Talk Lifts Interest

Retail traders are watching ImmunityBio (IBRX) after speculation that the stock could shift from the Russell 2000 to the Russell 1000, a potential index change that has already coincided with a 1% after-hours move. See our latest analysis for ImmunityBio. Beyond the index speculation, ImmunityBio’s recent 7 day share price return of 8.93% sits alongside a 90 day share price decline of 9.29% and a very large year to date share price gain of 262.38%. Meanwhile, the 1 year total shareholder...